Healthcare IT business of Religare Technologies has now announced the launch of HealthLine 24×7,India’s first phone-based and web-based healthcare information assistance service,in Kolkata, Chennai and Pune.
Schiller India, a leading Swiss Joint Venture Company in the field of Medical Diagnostics, has relaunched its popular series of Patient Monitors called SAMIKSH plus with many new and improved features.
The implementation of this system has been successfully completed at S.L. Raheja Hospitalin Mumbai, also a Fortis Healthcare associate.
SoftLink International Conducts Angio Review Session at CSI PTCA Registry 2010 Annual PTCA Registry 2010 was conducted in Bhubneshwar, where […]
[This article was published in the May 2011 issue of the eHEALTH Magazine (https://www.ehealthonline.org) ] Philips is the global leader in patient monitoring and the path-breaker in converting patient monitors into full fledged clinical aiding tools
Trivitron and Brandon Medical (UK) announces JV for manufacturing advanced OT Lights in IndiaTrivitron recently announced its alliance with Brandon […]
Mount Kellett Capital Management , US private equity group, is investing Rs 410 crore in one of India’s top pharma retailer MedPlus Health Services.
Cerner moves into Ireland Cerner, a leading international supplier of healthcare information technology (HIT) solutions, recently announced the opening of […]
Religare Technologies has come up with a Health helpline in three metros Delhi, Bangalore, and Mumbai so far.
It is uncanny to imagine a defence officer, who once held the responsibility of operating army tanks, is now a well-known CEO of a leading hospital in the country and saving lives of thousands of ailing patients each day
The DCGI now suspends the license of the Parenteral Surgical India Pvt Ltd. after using the contaminated IV fluids at Jodhpur hospitals.
[This article was published in the February 2011 issue of the eHEALTH Magazine (https://www.ehealthonline.org) ] After taking the telecom sector by storm, mobile phones are set to change the way healthcare is delivered
The Drugs Controller-General of India (DCGI) gave a go-ahead to the Serum Institute of India (SSI) to start human clinical trials of the intra-nasal spray developed to combat the spread of the lethal swine flu.
